Wednesday, July 31, 2019 8:35:52 AM
What is Chen Buying? What is Chen Selling?
Letter 2195
July 22, 2019
Update:
Last week was a big week for me, not only silver did great, my Neptune Wellness Solutions Inc. (NEPT) and Acasti Pharma Inc. (ACST) both exploded. NEPT did a financing with mostly large shareholders and insiders. Remember shorts were all over NEPT as they smell blood of a raise. Before I left for vacation, I asked large shareholders of NEPT to consider doing a financing at a small premium to send the shorts a strong message. I am very pleased to see this 4.4 financing mostly by large shareholders and insiders. My friend George Haywood called it “the most impressive insider buying I have ever seen!“ You can see from the filing, Perceptive increased its stake to 15%, CEO and Chairman put in 5 million despite they already owned millions of shares. Every large shareholders participated including my friend Haywood et al. Plus this financing comes with conditions that the buyers can't sell any shares, exisitng or new for months to come. Basically the shorts are in a box and getting ready to be squeezed hard. We should have very exciting news coming starting with closing the US plant this month.
ACST is doing great thanks to a new research report Oppenheimer came out. It gave 7 dollar target assuming 30% chance of success. Personally I believe the chance of success is more close to 90%. As I discussed, tens millions of shares will likely be purchased before the data readout in December. I am holding my shares here. If you don't wish to take any risks, you can sell some before the data and make it zero cost into the data, which is likely coming out in December.
Regards,
Chen
Recent ACST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 01:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 12:30:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 01:00:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 12:30:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:08:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:08:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 09:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/15/2023 12:30:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 12:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:30:18 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/16/2023 08:31:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 08:30:09 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 10/06/2023 08:30:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 11:46:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2023 12:10:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 07:54:48 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/25/2023 09:01:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/25/2023 08:21:04 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/25/2023 08:15:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 11:31:17 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2023 09:30:28 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM